-
Supported By:

Subscribe or Follow
Program on Corporate Governance Advisory Board
- Peter Atkins
- David Bell
- Kerry E. Berchem
- Richard Brand
- Daniel Burch
- Paul Choi
- Jesse Cohn
- Arthur B. Crozier Christine Davine
- Renata J. Ferrari
- Andrew Freedman
- Ray Garcia
- Byron Georgiou
- Joseph Hall
- Jason M. Halper William P. Mills
- David Millstone
- Theodore Mirvis
- Philip Richter
- Elina Tetelbaum
- Sebastian Tiller
- Marc Trevino Jonathan Watkins
- Steven J. Williams
HLS Faculty & Senior Fellows
Author Archives: Harvard Law School Forum on Corporate Governance and Financial Regulation
Buyback Critics Are Not Letting the COVID-19 Crisis Go to Waste
Critics of stock buybacks, heeding Rahm Emanuel, are not letting a serious crisis go to waste. They found a way to blame repurchases for COVID-19’s economic fallout, and are exploiting COVID-19 to try to curb their use. But critics’ claims are faulty, and proposed buyback restrictions may well exacerbate COVID-19’s ill effects. Buyback critics have […]
Click here to read the complete post
Posted in Academic Research, Financial Crisis, HLS Research, Securities Regulation
Tagged Bailouts, Capital markets, CARES Act, COVID-19, Financial crisis, Repurchases, Securities regulation, Shareholder value
Comments Off on Buyback Critics Are Not Letting the COVID-19 Crisis Go to Waste
Rights Plans (“Poison Pills”) in the COVID-19 Environment—“On the Shelf and Ready to Go”?
The human and business challenges confronting America from the COVID-19 pandemic are unprecedented. These global challenges have also emerged during a time when most companies have unfortunately given up nearly all of the traditional and effective “takeover” defenses like classified boards, have structural profiles that do not deter (and may invite) opportunistic attack and whose […]
Click here to read the complete post
Posted in Boards of Directors, Corporate Elections & Voting, Practitioner Publications, Securities Regulation
Tagged Boards of Directors, COVID-19, Delaware law, Financial crisis, Firm valuation, Management, Market reaction, Poison pills, Proxy advisors, Proxy voting, Shareholder activism, Shareholder rights, Systemic risk, Takeover defenses
Comments Off on Rights Plans (“Poison Pills”) in the COVID-19 Environment—“On the Shelf and Ready to Go”?
COVID19 Legal Issues: Company Obligations and Risk
As the coronavirus disease 2019 (“COVID-19”) spreads across the globe, we are beginning to see the first major impacts on businesses, financial markets, and international trade and commerce, with analysts increasingly pessimistic about a near-term solution. In this climate, our clients should expect to confront a range of legal issues related to the outbreak and […]
Click here to read the complete post
Posted in Accounting & Disclosure, Practitioner Publications, Securities Regulation
Tagged Contracts, COVID-19, Disclosure, Financial reporting, Human capital, Risk, SEC, Securities regulation, Shocks
Comments Off on COVID19 Legal Issues: Company Obligations and Risk
Activists Will Show Their True Colors in COVID-19 Pandemic
As a result of the COVID-19 pandemic, a number of public companies have seen their market capitalization and value of their common stock decline precipitously. Fortunately for many companies who are not currently facing an activist attack, director nomination and business matter proposal deadlines for annual meetings have passed for the current proxy season. For […]
Click here to read the complete post
Posted in Boards of Directors, Mergers & Acquisitions, Practitioner Publications
Tagged Boards of Directors, COVID-19, Hedge funds, Long-Term value, Mergers & acquisitions, Proxy contests, Repurchases, Shareholder activism, Shareholder voting, Shocks
Comments Off on Activists Will Show Their True Colors in COVID-19 Pandemic
Glass Lewis’ Approach to Governance in Times of the Coronavirus Pandemic
The Coronavirus (COVID-19) pandemic is expected to continue for up to 18 months. With the extraordinary impact the pandemic is already having on companies and markets around the world today, Glass Lewis has been scenario planning in order to consider how this will impact governance and broader ESG issues in the present and future. As […]
Click here to read the complete post
Posted in Boards of Directors, Corporate Elections & Voting, ESG, Institutional Investors, Practitioner Publications
Tagged Board performance, Boards of Directors, COVID-19, Dividends, Engagement, ESG, Executive Compensation, Institutional Investors, Pay for performance, Proxy advisors, Repurchases, Shareholder activism, Shareholder meetings, Shareholder proposals, Shareholder voting, Virtual meetings
Comments Off on Glass Lewis’ Approach to Governance in Times of the Coronavirus Pandemic
Lessons from 2008 for Management and the Board
This second week of March, company management and boards of directors have been confronted with a tumultuous decline in stock prices reminiscent of the 2008 Great Recession, albeit triggered by very different circumstances. Although the causes are different, there are lessons and experiences in the context of M&A and activism from the days and months […]
Click here to read the complete post
Posted in Accounting & Disclosure, Boards of Directors, Financial Crisis, Practitioner Publications
Tagged Boards of Directors, COVID-19, Financial crisis, Firm valuation, Market reaction, Poison pills, Shareholder activism, Systemic risk, Takeover defenses
Comments Off on Lessons from 2008 for Management and the Board
COVID-19 and Shareholder Activism—The Impact
No area is immune from the effects of the current COVID-19 crisis, including shareholder activism. For shareholders contemplating or already conducting an activist type campaign at a company, COVID-19 leads to logistical impediments and shifts in timing and strategy, but, importantly, also creates opportunities for savvy investors. Practical Impediments in Director Nominations At this time […]
Click here to read the complete post
Posted in Mergers & Acquisitions, Practitioner Publications, Securities Regulation
Tagged Boards of Directors, Hedge funds, Mergers & acquisitions, Proxy contests, SEC, Securities regulation, Shareholder activism, Shareholder nominations, Solicitation
Comments Off on COVID-19 and Shareholder Activism—The Impact
COVID-19: What Compensation Committees Should Be Thinking About Today
The COVID-19 pandemic has in a matter of weeks upended life in America, including in American business. Public companies have witnessed dramatic decreases in market value and business challenges that were largely unexpected weeks ago. Executive compensation programs must adjust to the new reality and continue to motivate leadership and performance. While every company will […]
Click here to read the complete post
Posted in Executive Compensation, Practitioner Publications
Tagged Change in control, COVID-19, Equity-based compensation, Executive Compensation, Incentives, Management, Pay for performance
Comments Off on COVID-19: What Compensation Committees Should Be Thinking About Today
“Stop, Look and Listen”—Improving the SEC’s Proposed Rules on Proxy Advisors
Executive Summary The publication of a “Stop, Look and Listen” communication is explicitly embraced in the SEC’s tender offer rules as a method for alerting shareholders that more information will soon be available that could influence their decision to tender or retain their shares. Such communications ask investors to pause until the target of the […]
Click here to read the complete post
Posted in Corporate Elections & Voting, Institutional Investors, Practitioner Publications, Securities Regulation
Tagged Council of Institutional Investors, Glass Lewis, Institutional Investors, Proxy advisors, Proxy voting, Rule 14a-2, SEC, SEC rulemaking, Securities regulation, Shareholder voting
Comments Off on “Stop, Look and Listen”—Improving the SEC’s Proposed Rules on Proxy Advisors